Vimarsana
Biggest News Aggregation in the World

Page 2 - External Expert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from External Expert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In External Expert Today - Breaking & Trending Today

Customs, IMF collaborate on implementation of AfCFTA - Vimarsana News

Customs, IMF collaborate on implementation of AfCFTA

The International Monetary Fund (IMF) and the Nigeria Customs Service (NCS), have commenced arrangements to review the status of operations concerning the implementation of rules of origin under the African Continental Free Trade Agreement (AfCFTA).

Time to Abolish Metrics That Sustain Systemic Racism in Kidney Allocation - Vimarsana News

Time to Abolish Metrics That Sustain Systemic Racism in Kidney Allocation

This Viewpoint discusses how the Kidney Donor Profile Index (KDPI)in its current form is not fit to guide kidney allocation because it devalues organ donation b

James Mawanda - Vimarsana News

James Mawanda

Convening the communication and media (for) development, social and behavioural change community through a social networking and shared knowledge strategy. Focus on health, governance, HIV/AIDS, children, media development, conflict management, environment, rights, disasters, gender and other major Development issues.

Journalist who sued BBC after being branded too 'loud and shouty' loses racial discrimination claim - Vimarsana News

Journalist who sued BBC after being branded too 'loud and shouty' loses racial discrimination claim

Ahmed Rouaba is said to have upset colleagues at the BBC World Service when he spoke 'violently' after being asked to address the meeting in 'formal Arabic' rather than 'Algerian Arabic.'

Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer - Vimarsana News

Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer

/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...